Differential expression of the 67 kilodalton laminin receptor in epithelioid malignant mesothelioma and carcinomas that spread to serosal cavities

Diagnostic Cytopathology

Volumn 33, Issue 5, 2005, Pages 332-337

  Reich, Reuven ^a,b   Vintman, Lina ^a   Nielsen, Søren ^c   Kærn, Janne ^d   Bedrossian, Carlos ^e   Berner, Aasmund ^d   Davidson, Ben ^d,f  

^a HEBREW UNIVERSITY OF JERUSALEM   (Israel)

^b HEBREW UNIVERSITY OF JERUSALEM   (Israel)

^c AALBORG UNIVERSITY HOSPITAL   (Denmark)

^d UNIVERSITY OF OSLO   (Norway)

^e NORTHWESTERN UNIVERSITY   (United States)

^f OSLO UNIVERSITY HOSPITAL   (Norway)

Author keywords

Carcinoma; Laminin receptor; Malignant mesothelioma; Metastasis

Indexed keywords

LAMININ; LAMININ RECEPTOR; MESSENGER RNA;

ADULT; AGED; BREAST CARCINOMA; CONFERENCE PAPER; CONTROLLED STUDY; DIFFERENTIAL DIAGNOSIS; FEMALE; HUMAN; HUMAN CELL; IMMUNOCYTOCHEMISTRY; MALE; MALIGNANT MESOTHELIOMA; MESOTHELIUM CELL; METASTASIS; OVARY CARCINOMA; PERITONEUM EXUDATE; PERITONEUM MESOTHELIOMA; PLEURA EFFUSION; PLEURA MESOTHELIOMA; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SEROSA;

ADENOCARCINOMA; ADULT; AGED; AGED, 80 AND OVER; ASCITIC FLUID; BREAST NEOPLASMS; FEMALE; HUMANS; MALE; MESOTHELIOMA; MIDDLE AGED; MOLECULAR WEIGHT; NEOPLASM INVASIVENESS; OVARIAN NEOPLASMS; PLEURAL EFFUSION, MALIGNANT; RECEPTORS, LAMININ; RNA, MESSENGER;

EID: 27744567209     PISSN: 87551039     EISSN: None     Source Type: Journal    
DOI: 10.1002/dc.20296     Document Type: Conference Paper

References (30)

1. Britton M. The epidemiology of mesothelioma. Semin Oncol 2002;29:18-25.
2. Sandberg AA, Bridge JA. Updates on the cytogenetics and molecular genetics of bone and soft tissue tumors. Mesothelioma Cancer Genet Cytogenet 2001;127:93-110.
3. van Ruth S, Baas P, Zoetmulder FAN. Surgical treatment of malignant pleural mesothelioma. Chest 2003;123:551-561.
4. Bedrossian CWM. Malignant effusions: a multimodal approach to cytologic diagnosis. New York: Igaku-Shoin Medical Publishers: 1994.
5. Bedrossian CWM. Diagnostic problems in serous effusions. Diagn Cytopathol 1998;19:131-137.
6. Gordon GJ, Jensen RV, Hsiao LL, et al. Translation of microarray data into clinically relevant cancer diagnostic tests using gene expression ratios in lung cancer and mesothelioma. Cancer Res 2002;62:4963-4967.
7. Kleinman HK, Koblinski J, Lee S, Engbring J. Role of basement membrane in tumor growth and metastasis. Sure Oncol Clin N Am 2001;10:329-338.
8. Hood JD, Cheresh DA. Role of integrins in cell invasion and migration. Nat Rev Cancer 2002;2:91-100.
9. Ruoslahti E. Integrins. J Clin Invest 1991;87:1-5.
10. Sanders RJ, Mainiero F, Giancotti FP. The role of integrins in tumorigenesis and metastasis. Cancer Invest 1998;16:329-344.
11. Malinoff HL, Wicha MS. Isolation of a cell surface receptor protein for laminin from murine fibrosarcoma cells. J Cell Biol 1983;96:1475-1479.
12. Rao M, Barsky SH, Terranova VP, Liotta LA. Isolation of a tumor cell laminin receptor. Biochem Biophys Res Commun 1983;111:804-808.
13. Menard S, Castronovo V, Tagliabue E, Sobel ME. New insights into the metastasis-associated 67-kd laminin receptor. J Cell Biochem 1997;67:155-165.
14. Menard S, Tagliabue E, Colnaghi MI. The 67-kd laminin receptor as a prognostic factor in human cancer. Breast Cancer Res Treat 1998;52:137-145.
15. Klominek J, Sumitran Karupan S, Hauzenberger D. Differential motile response of human malignant mesothelioma cells to fibronectin, laminin and collagen type IV: the role of β1 integrins. Int J Cancer 1997;72:1034-1044.
16. Koukoulis GK, Shen J, Monson R, Warren RH, Virtanen I, Gould VE. Pleural mestheliomas have an integrin profile distinct from visceral carcinomas. Hum Pathol 1997;28:84-90.
17. Davidson B, Nielsen S, Christensen J, et al. The role of Desmin and N-cadherin in effusion cytology. A comparative study using established markers of mesothelial and epithelial cells. Am J Surg Pathol 2001;25:1405-1412.
18. Edwards JG, McLaren J, Jones JL, Waller DA, O'Byrne KJ. Matrix metalloproteinases 2 and 9 (gelatinases A and B) expression in malignant mesothelioma and benign pleura. Br J Cancer 2003;88:1553-1559.
19. Kettunen E, Nissen AM, Ollikainen T, et al. Gene expression profiling of malignant mesothelioma cell lines: cDNA array study. Int J Cancer 2001;91:492-496.
20. Rihn BH, Mohr S, McDowell SA, et al. Differential gene expression in mesothelioma. FEBS Lett 2000;480:95-100.
21. Singhal S, Wiewrodt R, Maiden LD, et al. Gene expression profiling in malignant mesothelioma. Clin Cancer Res 2003;9:3080-3097.
22. Ardini E, Sporchia B, Pollegioni L, et al. Identification of a novel function for 67-kd laminin receptor: increase in laminin degradation rate and release of motility fragments. Cancer Res 2002;62:1321-1325.
23. Vande Broek I, Vanderkerken K, De Greef C, et al. Laminin-1-induced migration of multiple of multiple myeloma cells involves the high-affinity 67-kd laminin receptor. Br J Cancer 2001;85:1387-1395.
24. Narumi K. Inoue A, Tanaka M, et al. Inhibition of experimental metastasis of human fibrosarcoma cells by anti-recombinant 37-kd laminin binding protein antibody. Jpn J Cancer Res 1999;90:425-431.
25. Givant-Horwitz V, Davidson B, Reich R. Laminin-induced signaling in tumor cells: the role of the 67-kd laminin receptor. Cancer Res 2004;64:3572-3579.
26. Putz E, Witter K, Offner S, et al. Phenotypic characteristics of cell lines derived from disseminated cancer cells in bone marrow of patients with solid epithelial tumors: establishment of working models for human micrometastases. Cancer Res 1999;59:241-248.
27. Lee WA, Kim WH, Kim Yi, Yank HK, Kim JP, Kleinman HK. Overexpression of the 67-kd laminin receptor correlates with the progression of gastric carcinoma. Pathol Res Pract 1996;192:1195-1201.
28. Sanjuan X, Fernandez PL, Miquel R, et al. Overexpression of the 67-kd laminin receptor correlates with tumour progression in human colorectal carcinoma. J Pathol 1996;179:376-380.
29. Menard S, Squiciarini P, Luini A, et al. Immunodetection of bone marrow micrometastases in breast carcinoma patients and its correlation with primary tumor prognostic features. Br J Cancer 1994;69:1126-1129.
30. Sigstad E, Dong HP, Nielsen S, Berner A, Davidson B, Risberg B. Quantitative analysis of integrin expression in effusions using flow cytometric immunophenotyping. Diagn Cytopathol 2005;33:249-255.